Edition:
United States

Cardiovascular Systems Inc (CSII.OQ)

CSII.OQ on NASDAQ Stock Exchange Global Select Market

27.52USD
22 Sep 2017
Change (% chg)

$-0.11 (-0.40%)
Prev Close
$27.63
Open
$27.40
Day's High
$27.71
Day's Low
$27.33
Volume
76,334
Avg. Vol
90,187
52-wk High
$33.10
52-wk Low
$21.29

Chart for

About

Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral... (more)

Overall

Beta: 2.56
Market Cap(Mil.): $907.93
Shares Outstanding(Mil.): 32.99
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.51 16.34
EPS (TTM): -- -- --
ROI: -- 13.78 14.66
ROE: -- 16.61 14.00

BRIEF-Cardiovascular Systems announces anticipated revenue impact from hurricanes

* Cardiovascular Systems announces anticipated revenue impact from hurricanes Harvey and Irma

Sep 18 2017

BRIEF-Cardiovascular Systems Q4 earnings per share $0.02

* Cardiovascular Systems, Inc. Reports fiscal 2017 fourth-quarter financial results

Aug 02 2017

BRIEF-Brown Capital Management LLC reports 7.56 pct passive stake in Cardiovascular Systems

* Brown Capital Management LLC reports 7.56 percent passive stake in Cardiovascular Systems Inc as of June 30 - sec filing Source text : http://bit.ly/2u638Ru Further company coverage:

Jul 10 2017

Judge cuts $25 mln retaliation verdict against Cardiovascular Systems

A California judge has slashed a $25.1 million jury award to a former Cardiovascular Systems Inc employee who claimed the medical device maker retaliated against him for complaining about what he said was off-label marketing and a scheme to pay doctors kickbacks.

Jul 05 2017

BRIEF-Cardiovascular Systems says on June 27, Plaintiffs filed an amended complaint regarding Shoemaker V. Cardiovascular Systems case

* Cardiovascular Systems - On June 27, 2017, Plaintiffs filed an amended complaint regarding Shoemaker V. Cardiovascular Systems case

Jun 29 2017

BRIEF-Cardiovascular Systems Q3 loss per share $0.05

* Cardiovascular Systems Inc reports fiscal 2017 third-quarter financial results

May 03 2017

Cardiovascular Systems must pay $25 million for retaliation - jury

Cardiovascular Systems Inc has been ordered to pay $25.1 million to a former employee who claimed the medical device manufacturer retaliated against him for complaining about what he said was off-label marketing and a scheme to pay doctors kickbacks.

Apr 26 2017

BRIEF-Cardiovascular Systems updates on former employee case

* Cardiovascular Systems says jury awarded plaintiff $2.7 million compensatory damages for claims for whistleblower retaliation, wrongful termination

Apr 26 2017

Judge tosses Cardiovascular Systems investors' kickback case

Cardiovascular Systems Inc has won the dismissal of a class action lawsuit accusing the medical-device maker of failing to disclose to investors that it relied on illegal kickbacks to doctors and off-label promotions to drive up sales.

Mar 30 2017

BRIEF-Cardiovascular Systems receives approval for Diamondback 360 coronary orbital atherectomy system Micro Crown in the United States

* Cardiovascular Systems, Inc. receives approval for the Diamondback 360® coronary orbital atherectomy system (oas) micro crown in the United States

Mar 30 2017

Earnings vs. Estimates